Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in Early Parkinson's Disease
NCT00004731Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Sep 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of coenzyme q10 in Parkinson's disease (PD) (4 arms), sponsored by National Institute of Neurological Disorders and Stroke. Primary endpoint: Time to Requirement of Levodopa Treatment at 16 months. Started Sep 1998; status: completed.
02
Drugs
coenzyme q10
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00004731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004731.